These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 36620154)
1. Tumor metabolism derived from Hu S; Xie Y; Yang T; Yang Y; Zou Q; Jiao J; Zhang Y Quant Imaging Med Surg; 2023 Jan; 13(1):309-319. PubMed ID: 36620154 [TBL] [Abstract][Full Text] [Related]
2. Hu S; Kang Y; Xie Y; Yang T; Yang Y; Jiao J; Zou Q; Zhang H; Zhang Y Abdom Radiol (NY); 2023 Feb; 48(2):532-542. PubMed ID: 36370179 [TBL] [Abstract][Full Text] [Related]
3. Macrotrabecular-massive hepatocellular carcinoma: imaging identification and prediction based on gadoxetic acid-enhanced magnetic resonance imaging. Chen J; Xia C; Duan T; Cao L; Jiang H; Liu X; Zhang Z; Ye Z; Wu Z; Gao R; Shi Y; Song B Eur Radiol; 2021 Oct; 31(10):7696-7704. PubMed ID: 33856520 [TBL] [Abstract][Full Text] [Related]
4. Preoperative prediction model for macrotrabecular-massive hepatocellular carcinoma based on contrast-enhanced CT and clinical characteristics: a retrospective study. He C; Zhang W; Zhao Y; Li J; Wang Y; Yao W; Wang N; Ding W; Wei X; Yang R; Jiang X Front Oncol; 2023; 13():1124069. PubMed ID: 37197418 [TBL] [Abstract][Full Text] [Related]
6. Preoperative prediction of microvascular invasion of hepatocellular carcinoma using Hyun SH; Eo JS; Song BI; Lee JW; Na SJ; Hong IK; Oh JK; Chung YA; Kim TS; Yun M Eur J Nucl Med Mol Imaging; 2018 May; 45(5):720-726. PubMed ID: 29167923 [TBL] [Abstract][Full Text] [Related]
7. Comparison of computed tomography and magnetic resonance imaging findings and histopathological features of macrotrabecular-massive hepatocellular carcinoma. Gong Q; Zhang Y; Wu T; Du Z; Zhang Y Quant Imaging Med Surg; 2023 Jul; 13(7):4633-4640. PubMed ID: 37456331 [TBL] [Abstract][Full Text] [Related]
8. Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma based on B-Mode US and CEUS. Luo M; Liu X; Yong J; Ou B; Xu X; Zhao X; Liang M; Zhao Z; Ruan J; Luo B Eur Radiol; 2023 Jun; 33(6):4024-4033. PubMed ID: 36484835 [TBL] [Abstract][Full Text] [Related]
9. MRI imaging features for predicting macrotrabecular-massive subtype hepatocellular carcinoma: a systematic review and meta-analysis. Kim TH; Woo S; Lee DH; Do RK; Chernyak V Eur Radiol; 2024 Oct; 34(10):6896-6907. PubMed ID: 38507054 [TBL] [Abstract][Full Text] [Related]
10. Combined early dynamic Zhang Y; Dong Y; Yu W; Chen S; Yu H; Li B; Shi H Abdom Radiol (NY); 2023 Oct; 48(10):3127-3134. PubMed ID: 37439840 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of metabolic characteristics and viability of lipiodolized hepatocellular carcinomas using 18F-FDG PET/CT. Kim HO; Kim JS; Shin YM; Ryu JS; Lee YS; Lee SG J Nucl Med; 2010 Dec; 51(12):1849-56. PubMed ID: 21098794 [TBL] [Abstract][Full Text] [Related]
12. Value of 18F-FDG PET/CT in detecting viable tumour and predicting prognosis of hepatocellular carcinoma after TACE. Song HJ; Cheng JY; Hu SL; Zhang GY; Fu Y; Zhang YJ Clin Radiol; 2015 Feb; 70(2):128-37. PubMed ID: 25459673 [TBL] [Abstract][Full Text] [Related]
13. Elevated tumor-to-liver uptake ratio (TLR) from Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134 [TBL] [Abstract][Full Text] [Related]
14. Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT. Mulé S; Chalaye J; Legou F; Tenenhaus A; Calderaro J; Galletto Pregliasco A; Laurent A; Kharrat R; Amaddeo G; Regnault H; Tacher V; Kobeiter H; Itti E; Luciani A Eur Radiol; 2020 Oct; 30(10):5348-5357. PubMed ID: 32405753 [TBL] [Abstract][Full Text] [Related]
15. A radiomics nomogram based on contrast-enhanced MRI for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma. Zhu Y; Weng S; Li Y; Yan C; Ye R; Wen L; Zhou L; Gao L Abdom Radiol (NY); 2021 Jul; 46(7):3139-3148. PubMed ID: 33641018 [TBL] [Abstract][Full Text] [Related]
16. Preoperative CT for Characterization of Aggressive Macrotrabecular-Massive Subtype and Vessels That Encapsulate Tumor Clusters Pattern in Hepatocellular Carcinoma. Feng Z; Li H; Zhao H; Jiang Y; Liu Q; Chen Q; Wang W; Rong P Radiology; 2021 Jul; 300(1):219-229. PubMed ID: 33973839 [TBL] [Abstract][Full Text] [Related]
17. 2-[ Zhao Y; Wu C; Li W; Chen X; Li Z; Liao X; Cui Y; Zhao G; Liu M; Fu Z Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):570-579. PubMed ID: 32814979 [TBL] [Abstract][Full Text] [Related]
18. 18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma. Lee M; Jeon JY; Neugent ML; Kim JW; Yun M Clin Exp Metastasis; 2017 Apr; 34(3-4):251-260. PubMed ID: 28429188 [TBL] [Abstract][Full Text] [Related]
19. Imaging features of histological subtypes of hepatocellular carcinoma: Implication for LI-RADS. Cannella R; Dioguardi Burgio M; Beaufrère A; Trapani L; Paradis V; Hobeika C; Cauchy F; Bouattour M; Vilgrain V; Sartoris R; Ronot M JHEP Rep; 2021 Dec; 3(6):100380. PubMed ID: 34825155 [TBL] [Abstract][Full Text] [Related]
20. Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation. Lin CY; Liao CW; Chu LY; Yen KY; Jeng LB; Hsu CN; Lin CL; Kao CH Clin Nucl Med; 2017 Apr; 42(4):e183-e187. PubMed ID: 28114226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]